Cosette M Wheeler
Overview
Explore the profile of Cosette M Wheeler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
7631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adcock R, Wheeler C, Hunt W, Torrez-Martinez N, Robertson M, McDonald R, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40069924
Background: Following human papillomavirus (HPV) vaccine introduction, declines in the prevalence of HPV vaccine types have been observed in screening cytology, but data from the United States describing HPV type-specific...
2.
Wheeler C, Adcock R, Hunt W, Robertson M, Torrez-Martinez N, McDonald R, et al.
J Natl Cancer Inst
. 2024 Dec;
PMID: 39658224
Background: Various studies have reported on the impact of human papillomavirus (HPV) vaccines. Here we present the largest population-based investigation of genotype-specific distributions over the decade following implementation of the...
3.
Spencer J, Wheeler C
Cancer Epidemiol Biomarkers Prev
. 2024 Aug;
33(8):982-983.
PMID: 39086313
Cervical cancer screening has reduced morbidity and mortality in many countries, but efforts to optimize screening modalities and schedules are ongoing. Using data from a randomized trial conducted in British...
4.
Adcock R, Kang H, Castle P, Kinney W, Emeny R, Wiggins C, et al.
JAMA Oncol
. 2024 Jul;
10(9):1287-1290.
PMID: 39052303
No abstract available.
5.
Wheeler C, Torrez-Martinez N, Torres-Chavolla E, Parvu V, Andrews J, Du R, et al.
Am J Obstet Gynecol
. 2023 Oct;
230(2):243.e1-243.e11.
PMID: 37806613
Background: The US Food and Drug Administration supports innovations to facilitate new indications for high-risk human papillomavirus testing. This report describes the retrospective testing of stored specimens and analysis of...
6.
Cuzick J, Adcock R, Kinney W, Castle P, Robertson M, McDonald R, et al.
Int J Cancer
. 2023 Mar;
153(1):83-93.
PMID: 36946690
Human papillomavirus (HPV) testing for cervical screening increases diagnosis of precancer and reduces the incidence of cervical cancer more than cytology alone. However, real-world evidence from diverse practice settings is...
7.
Del Vecchio N, Beaber E, Garcia M, Wheeler C, Kamineni A, Chao C, et al.
J Low Genit Tract Dis
. 2023 Feb;
27(2):113-119.
PMID: 36728078
Objectives: Reproducibility of cervical biopsy diagnoses is low and may vary based on where the diagnostic test is performed and by whom. Our objective was to measure multilevel variation in...
8.
Chao C, Chubak J, Beaber E, Kamineni A, Mao C, Silverberg M, et al.
Cancer Med
. 2022 Sep;
12(3):3705-3717.
PMID: 36106421
Background: Potential care gaps in the cervical cancer screening process among women diagnosed with cervical cancer in an era with increased human papillomavirus (HPV) testing have not been extensively evaluated....
9.
Brown D, Castellsague X, Ferris D, Garland S, Huh W, Steben M, et al.
Tumour Virus Res
. 2022 May;
13:200236.
PMID: 35525430
Background: Estimates of the humoral immune response to incident human papillomavirus (HPV) infections are limited. Methods: In this post hoc analysis of 3875 women aged 16-23 years from a 4-valent...
10.
Adcock R, Nedjai B, Lorincz A, Scibior-Bentkowska D, Banwait R, Torrez-Martinez N, et al.
Int J Cancer
. 2022 Apr;
151(7):993-1004.
PMID: 35477862
Methylation of host and viral genes is promising for triage of women with high-risk human papillomavirus infections (hrHPV). Using a population-based sample of hrHPV positive women with cervical biopsies within...